157 related articles for article (PubMed ID: 25699138)
21. Synthesis and Structure-Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors.
Singh A; Kast J; Dirain ML; Huang H; Haskell-Luevano C
ACS Chem Neurosci; 2016 Feb; 7(2):196-205. PubMed ID: 26645732
[TBL] [Abstract][Full Text] [Related]
22. Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors.
Holder JR; Marques FF; Xiang Z; Bauzo RM; Haskell-Luevano C
Eur J Pharmacol; 2003 Feb; 462(1-3):41-52. PubMed ID: 12591094
[TBL] [Abstract][Full Text] [Related]
23. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
24. A solid-phase approach to mouse melanocortin receptor agonists derived from a novel thioether cyclized peptidomimetic scaffold.
Bondebjerg J; Xiang Z; Bauzo RM; Haskell-Luevano C; Meldal M
J Am Chem Soc; 2002 Sep; 124(37):11046-55. PubMed ID: 12224952
[TBL] [Abstract][Full Text] [Related]
25. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions.
Haskell-Luevano C; Lim S; Yuan W; Cone RD; Hruby VJ
Peptides; 2000 Jan; 21(1):49-57. PubMed ID: 10704719
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology.
Ericson MD; Wilczynski A; Sorensen NB; Xiang Z; Haskell-Luevano C
J Med Chem; 2015 Jun; 58(11):4638-47. PubMed ID: 25898270
[TBL] [Abstract][Full Text] [Related]
27. 1,2,3-Triazole Rings as a Disulfide Bond Mimetic in Chimeric AGRP-Melanocortin Peptides: Design, Synthesis, and Functional Characterization.
Tala SR; Singh A; Lensing CJ; Schnell SM; Freeman KT; Rocca JR; Haskell-Luevano C
ACS Chem Neurosci; 2018 May; 9(5):1001-1013. PubMed ID: 29257879
[TBL] [Abstract][Full Text] [Related]
28. A Macrocyclic Agouti-Related Protein/[Nle
Ericson MD; Freeman KT; Schnell SM; Haskell-Luevano C
J Med Chem; 2017 Jan; 60(2):805-813. PubMed ID: 28045525
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors. Part 3: modifications at the Arg position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
Peptides; 2003 Jan; 24(1):73-82. PubMed ID: 12576087
[TBL] [Abstract][Full Text] [Related]
30. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
31. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biophysical, and pharmacological evaluation of the melanocortin agonist AST3-88: modifications of peptide backbone at Trp 7 position lead to a potent, selective, and stable ligand of the melanocortin 4 receptor (MC4R).
Singh A; Dirain ML; Wilczynski A; Chen C; Gosnell BA; Levine AS; Edison AS; Haskell-Luevano C
ACS Chem Neurosci; 2014 Oct; 5(10):1020-31. PubMed ID: 25141170
[TBL] [Abstract][Full Text] [Related]
33. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.
Haskell-Luevano C; Holder JR; Monck EK; Bauzo RM
J Med Chem; 2001 Jun; 44(13):2247-52. PubMed ID: 11405661
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
[TBL] [Abstract][Full Text] [Related]
35. Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa
Doering SR; Freeman KT; Schnell SM; Haslach EM; Dirain M; Debevec G; Geer P; Santos RG; Giulianotti MA; Pinilla C; Appel JR; Speth RC; Houghten RA; Haskell-Luevano C
J Med Chem; 2017 May; 60(10):4342-4357. PubMed ID: 28453292
[TBL] [Abstract][Full Text] [Related]
36. Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist Tetrapeptide.
Ericson MD; Larson CM; Freeman KT; Nicke L; Geyer A; Haskell-Luevano C
ACS Omega; 2022 Aug; 7(31):27656-27663. PubMed ID: 35967074
[TBL] [Abstract][Full Text] [Related]
37. Melanocortin tetrapeptides modified at the N-terminus, His, Phe, Arg, and Trp positions.
Holder J; Haskell-Luevano C
Ann N Y Acad Sci; 2003 Jun; 994():36-48. PubMed ID: 12851296
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist.
Fleming KA; Freeman KT; Powers MD; Santos RG; Debevec G; Giulianotti MA; Houghten RA; Doering SR; Pinilla C; Haskell-Luevano C
J Med Chem; 2019 Mar; 62(5):2738-2749. PubMed ID: 30741545
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and activity of the melanocortin Xaa-d-Phe-Arg-Trp-NH tetrapeptides with amide bond modifications.
Todorovic A; Holder JR; Scott JW; Haskell-Luevano C
J Pept Res; 2004 Mar; 63(3):270-8. PubMed ID: 15049839
[TBL] [Abstract][Full Text] [Related]
40. The Parallel Structure-Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands.
Ericson MD; Freeman KT; LaVoi TM; Donow HM; Santos RG; Giulianotti MA; Pinilla C; Houghten RA; Haskell-Luevano C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
